Jacquelot, Nicolas
Zitvogel, Laurence
Eggermont, Alexander M.
Article History
Received: 13 March 2018
Accepted: 13 June 2018
First Online: 26 July 2018
Competing interests
: A.M.E. participated on scientific advisory boards for Actelion, Agenus, Bayer, BMS, GlaxoSmithKline, HalioDx, Incyte, MSD, Nektar, Novartis, Pfizer, and Sanofi. L.Z. is on the Transgene administrative board and Lytix Pharma scientific advisory board and is the main founder of EverImmune. The remaining author declares no competing interests.